"10.1371_journal.pone.0011995","plos one","2010-08-10T00:00:00Z","Barney S Graham; M Juliana McElrath; Michael C Keefer; Kyle Rybczyk; David Berger; Kent J Weinhold; Janet Ottinger; Guido Ferarri; David C Montefiori; Don Stablein; Carol Smith; Richard Ginsberg; John Eldridge; Ann Duerr; Pat Fast; Barton F Haynes; the AIDS Vaccine Evaluation Group","Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Fred Hutchinson Cancer Research Center, University of Washington at Seattle, Seattle, Washington, United States of America; University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America; Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America; Duke University School of Medicine, Durham, North Carolina, United States of America; EMMES Corporation, Rockville, Maryland, United States of America; Profectus Biosciences, Inc., Tarrytown, New York, United States of America; International AIDS Vaccine Initiative, New York, New York, United States of America","Conceived and designed the experiments: BSG MJM MCK KW JO GF DCM DS CS PF BFH. Performed the experiments: BSG MJM MCK KR DB KW JO GF DCM BFH. Analyzed the data: BSG MJM MCK KW JO GF DCM DS CS AD PF BFH. Contributed reagents/materials/analysis tools: BSG MJM KW JO GF DCM DS CS RG JE BFH. Wrote the paper: BSG MCK KR DB KW DS CS AD PF BFH.","Barton F. Haynes was involved in the conceptual development of the peptide vaccine. Neither the EMMES Corporation nor Profectus Biosciences have competing intellectual or financial interests related to the products discussed in this manuscript. All the authors agree to adhere to the PLoS ONE policies on sharing data and materials.","2010","08","Barney S Graham","BSG",17,TRUE,11,10,12,10,TRUE,TRUE,FALSE,0,NA,FALSE
